Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) General Information
Description
Worldwide distribution rights of 2 specialty drugs. The rights allows production and sale of Buccastem, used for the treatment of nausea and vomiting, and Timodine, a anti-fungal and anti-bacterial skin cream used for treating inflamed and infected skin conditions.
Contact Information
Corporate Office
- 103 - 105 Bath Road
- Slough SL1 3UH
- England, United Kingdom
Corporate Office
- 103 - 105 Bath Road
- Slough SL1 3UH
- England, United Kingdom
Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) FAQs
-
Where is Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) headquartered?
Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) is headquartered in Slough, United Kingdom.
-
What industry is Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) in?
Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)’s primary industry is Buildings and Property.
-
Is Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) a private or public company?
Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) is a Private company.
-
What is the current valuation of Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)?
The current valuation of Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) is
. -
What is Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)’s current revenue?
The current revenue for Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) is
. -
Who are Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)’s investors?
Reckitt Benckiser Group has invested in Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands).
-
When was Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) acquired?
Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) was acquired on 18-Aug-2009.
-
Who acquired Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)?
Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) was acquired by Alliance Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »